About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

January 20, 2016

Click here to read more

Post navigation

Phosphagenics Initiates Arbitration Against Mylan

Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial

Related Posts

Phosphagenics Launches New Logo and Website

November 5, 2014

2017 AGM Resuls

May 31, 2017

Avecho licenses TPM® for development of enhanced cancer drugs

May 22, 2023May 22, 2023

Recent Posts

Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.